-
1
-
-
0037371928
-
Post-marketing surveillance of abuse liability of sibutramine
-
Arfken C. L., Schuster C. R., Johanson C. E., Post-marketing surveillance of abuse liability of sibutramine. Drug and Alcohol Dependence 2003, 69, 169-173.
-
(2003)
Drug and Alcohol Dependence
, vol.69
, pp. 169-173
-
-
Arfken, C.L.1
Schuster, C.R.2
Johanson, C.E.3
-
2
-
-
0037173028
-
Identification and synthesis of some contaminants present in 4-methoxy-amphetamine (PMA) prepared by the Leuckart method
-
Błachut D., Wojtasiewicz K., Czarnocki Z., Identification and synthesis of some contaminants present in 4-methoxy-amphetamine (PMA) prepared by the Leuckart method, Forensic Science International 2002, 127, 45-62.
-
(2002)
Forensic Science International
, vol.127
, pp. 45-62
-
-
Błachut, D.1
Wojtasiewicz, K.2
Czarnocki, Z.3
-
3
-
-
34250304151
-
-
Buckett W. R., Hopcroft R. H., Luscombe G. P. [et al.], BTS 54525, a monoamine uptake inhibitor exhibiting potent actions in models predictive of potential antidepressant activity, British Journal of Pharmacology 1987, 90, 94.
-
Buckett W. R., Hopcroft R. H., Luscombe G. P. [et al.], BTS 54525, a monoamine uptake inhibitor exhibiting potent actions in models predictive of potential antidepressant activity, British Journal of Pharmacology 1987, 90, 94.
-
-
-
-
4
-
-
0033036174
-
et al.], Thermogenic effects of sibutramine and its metabolites
-
126
-
Connoley I. P., Liu Y. L., Frost I. [et al.], Thermogenic effects of sibutramine and its metabolites, British Journal of Pharmacology 1999, 126, 1487-1495.
-
(1999)
British Journal of Pharmacology
, pp. 1487-1495
-
-
Connoley, I.P.1
Liu, Y.L.2
Frost, I.3
-
5
-
-
0036597552
-
Sibutramine warning: Hypertension and cardiac arrhythmias reported
-
Deitel M., Sibutramine warning: hypertension and cardiac arrhythmias reported, Obesity Surgery 2002, 12, 422.
-
(2002)
Obesity Surgery
, vol.12
, pp. 422
-
-
Deitel, M.1
-
6
-
-
0034717220
-
et al.], Enantioselective behavioral effects of sibutramine metabolites
-
397
-
Glick S. D., Haskew R. E., Maissoneuve I. M. [et al.], Enantioselective behavioral effects of sibutramine metabolites, European Journal of Pharmacology 2000, 397, 93-102.
-
(2000)
European Journal of Pharmacology
, pp. 93-102
-
-
Glick, S.D.1
Haskew, R.E.2
Maissoneuve, I.M.3
-
7
-
-
0031740856
-
et al.], Thermogenic effects of sibutramine in humans
-
68
-
Hansen D. L., Toubro S., Stock M. J. [et al.], Thermogenic effects of sibutramine in humans, American Journal of Clinical Nutrition 1998, 68, 1180-1186.
-
(1998)
American Journal of Clinical Nutrition
, pp. 1180-1186
-
-
Hansen, D.L.1
Toubro, S.2
Stock, M.J.3
-
8
-
-
0030759773
-
-
Jackson H. C., Bearham M. C., Hutchins L. J. [et al.], Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor sibutramine in the rat, British Journal of Pharmacology 1997, 121, 1613-1618.
-
Jackson H. C., Bearham M. C., Hutchins L. J. [et al.], Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor sibutramine in the rat, British Journal of Pharmacology 1997, 121, 1613-1618.
-
-
-
-
9
-
-
33748960602
-
-
Jeffery J. E., Kerrigan F., Miller T. K. [et al.], Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its human metabolites, Journal of the Chemical Society 1996, 21, 2583-2589.
-
Jeffery J. E., Kerrigan F., Miller T. K. [et al.], Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its human metabolites, Journal of the Chemical Society 1996, 21, 2583-2589.
-
-
-
-
10
-
-
34250337149
-
Anorectic sibutramine detected in a Chinese herbal drug for weight loss: A case report Klein-Schwartz W., Toxicity of diet drugs
-
Jung J., Hermanns-Clausen M., Weinmann W., Anorectic sibutramine detected in a Chinese herbal drug for weight loss: a case report Klein-Schwartz W., Toxicity of diet drugs, Toxalert 1998, 15, 3.
-
(1998)
Toxalert
, vol.15
, pp. 3
-
-
Jung, J.1
Hermanns-Clausen, M.2
Weinmann, W.3
-
11
-
-
0032982982
-
-
Ku Y. R., Chang Y. S., Wen K. C. [et al.], Analysis and confirmation of synthetic anorexics in adulterated traditional Chinese medicines by high-performance capillary electrophoresis, Journal of Chromatography A 1999, 848, 537-543.
-
Ku Y. R., Chang Y. S., Wen K. C. [et al.], Analysis and confirmation of synthetic anorexics in adulterated traditional Chinese medicines by high-performance capillary electrophoresis, Journal of Chromatography A 1999, 848, 537-543.
-
-
-
-
12
-
-
0037066583
-
The discovery and status of sibutramine as an anti-obesity drug
-
Luque C. A., Rey J. A., The discovery and status of sibutramine as an anti-obesity drug, European Journal of Pharmacology 2002, 440, 119-128.
-
(2002)
European Journal of Pharmacology
, vol.440
, pp. 119-128
-
-
Luque, C.A.1
Rey, J.A.2
-
13
-
-
0034016898
-
-
Radhakrishna T., Lakshmi Narayana C., Sreenivas Rao D. [et al.], LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography, Journal of Pharmaceutical and Biomedical Analysis 2000, 22, 627-639.
-
Radhakrishna T., Lakshmi Narayana C., Sreenivas Rao D. [et al.], LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography, Journal of Pharmaceutical and Biomedical Analysis 2000, 22, 627-639.
-
-
-
-
14
-
-
0033984025
-
et al.], Abuse liability assessment of sibutramine, a novel weight control agent
-
147
-
Schuh L. M., Schuster C. R., Hopper J. A. [et al.], Abuse liability assessment of sibutramine, a novel weight control agent, Psychopharmacology 2000, 147, 339-346.
-
(2000)
Psychopharmacology
, pp. 339-346
-
-
Schuh, L.M.1
Schuster, C.R.2
Hopper, J.A.3
-
15
-
-
14944383697
-
Sibutramine: Possible cause of a reversible cardiomyopathy
-
Sayin T., Güldal M., Sibutramine: possible cause of a reversible cardiomyopathy, International Journal of Cardiology 2005, 99, 481-482.
-
(2005)
International Journal of Cardiology
, vol.99
, pp. 481-482
-
-
Sayin, T.1
Güldal, M.2
-
16
-
-
0036098099
-
Obesity drug sibutramine (Meridia): Hypertension and cardiac arrhythmias
-
Wooltorton E., Obesity drug sibutramine (Meridia): hypertension and cardiac arrhythmias, Canadian Medical Association Journal 2002, 166, 1307-1308.
-
(2002)
Canadian Medical Association Journal
, vol.166
, pp. 1307-1308
-
-
Wooltorton, E.1
|